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The herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) is the only abundant viral
transcript expressed in latently infected neurons. LAT inhibits apoptosis, suggesting that it regulates latency
by promoting the survival of infected neurons. The LAT locus also contains a newly described gene (AL), which
is antisense to LAT and partially overlaps LAT encoding sequences. When human (SK-N-SH) or mouse
(neuro-2A) neuroblastoma cells were infected with a virus that does not express LAT or AL gene products
(dLAT2903), beta interferon (IFN-) and IFN- RNA expression was detected earlier relative to the same cells
infected with HSV-1 strains that express LAT and AL. Infection of neuro-2A cells with dLAT2903 also led to
higher levels of IFN- promoter activity than in cells infected with wild-type (wt) HSV-1. In contrast, IFN RNA
expression was the same when human lung fibroblasts were infected with dLAT2903 or wt HSV-1. When
BALB/c mice were infected with dLAT2903, IFN- and IFN- RNA expression was readily detected in
trigeminal ganglia (TG) 4 days after infection. These transcripts were not detected in TG of mice infected with
wt HSV-1 or dLAT2903R (marker-rescued dLAT2903) until 6 days postinfection. When TG single-cell sus-
pensions from infected BALB/c mice were prepared and incubated in vitro with wt HSV-1 as a source of
antigen, TG cultures prepared from mice infected with dLAT2903 produced and secreted higher levels of IFN
protein than wt HSV-1 or dLAT2903R. Collectively, these studies suggest that the LAT locus interferes with and
delays IFN expression.
Approximately 90% of adults in the United States are in-
fected with herpes simplex virus type 1 (HSV-1) (38, 72). Re-
current ocular HSV-1 is the leading cause of infectious corneal
blindness in industrialized nations (40). HSV-1-induced en-
cephalitis (HSE) is a severe form of focal necrotizing enceph-
alitis that affects at least 2,000 individuals each year in the
United States (12, 29, 71, 72). Without antiviral therapy, the
mortality rate is as high as 70%; but even with antiviral ther-
apy, 20% of these patients die (59, 60). Although HSE was
considered a rare disorder, it is now clear that chemotherapy
and perhaps other forms of immunosuppression can lead to
HSE and/or bilateral acute retinal necrosis (41). Acute infec-
tion is typically initiated in the mucocutaneous epithelium, and
then HSV-1 establishes latency in sensory neurons located in
trigeminal ganglia (TG) or sacral dorsal root ganglia (20, 68).
Despite a vigorous immune response during acute infection,
latency is established and periodically reactivates.
A single region within the viral long repeats is abundantly
transcribed in latently infected neurons, and this transcript is
termed the latency-associated transcript (LAT) (6-8, 24, 35, 54,
61, 69, 70). Mice, rabbits, and humans latently infected with
HSV-1 express LAT. The primary LAT transcript is approxi-
mately 8.3 kb (8, 54, 75). Splicing of the 8.3-kb transcript yields
a stable 2-kb LAT and an unstable 6.3-kb LAT. The 2-kb LAT
can also be further spliced in infected neurons to yield a 1.4-
and a 1.5-kb transcript (30). The majority of the 2-kb LAT is
not capped, is not polyadenylated, and appears to be a circu-
larized stable intron (9, 25). Numerous mutants that do not
express detectable levels of LAT have been constructed (20,
68). The vast majority of studies using these mutants have
demonstrated that LAT significantly enhances the latency re-
activation cycle in small animal models (reviewed in references
20 and 21). The HSV-1 McKrae strain is frequently shed in
tears of infected rabbits because of spontaneous reactivation
(47-51). In contrast, spontaneous reactivation is severely im-
paired if the LAT gene is deleted (dLAT2903). dLAT2903
contains a deletion from 161 to 1667 relative to the start of
the primary 8.3-kb LAT and thus does not express detectable
levels of LAT (48, 49). Unlike the wild-type (wt) strain of
McKrae, dLAT2903 does not induce high levels of spontane-
ous reactivation in rabbits (48, 49) or high levels of induced
reactivation in mice (46). The spontaneous reactivation phe-
notype of dLAT2903 in rabbits and the explant-induced reac-
tivation phenotype of dLAT2903 in mice are restored to wild-
type levels when the first 1.5 kb of LAT (LAT nucleotides 1 to
1499) driven by the LAT promoter is inserted into an ectopic
location in the virus. This indicates that the first 1.5 kb of LAT,
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which contains only the first 837 nucleotides of the stable 2-kb
LAT and which does not have the high stability of the 2-kb
LAT, is sufficient to support high wild-type levels of reactiva-
tion in the rabbit and mouse (19, 49). HSV-1 17syn strain
mutants with deletions in the LAT promoter and 5 region of
LAT (approximately 1,200 bp) also do not reactivate efficiently
in the rabbit eye model (15, 65). These LAT mutants grow with
efficiencies similar to those of wt strains in cultured cells and in
acutely infected rabbits. LAT may also enhance establishment
of latency in mice (56, 64) and rabbits (52), which would
increase the pool of latently infected neurons, and conse-
quently may increase the frequency of reactivation from la-
tency. Within the LAT locus, a gene that is antisense to LAT
and partially overlaps the 5 terminus of LAT was recently
described and named antisense to LAT (AL) (44). Thus, the
LAT locus has at least three distinct genetic elements: the
stable 2-kb transcript, functions expressed from the first 1.5-kb
LAT coding sequences, and the AL gene.
LAT interferes with apoptosis in transiently transfected cells
(1, 16, 42, 45). The ability of LAT to interfere with apoptosis
correlates with its ability to promote spontaneous reactivation
(16, 19), suggesting the antiapoptotic activity of LAT has bio-
logical significance. Recent studies have demonstrated that
LAT-expressing plasmids inhibit caspase 8- and caspase 9-in-
duced apoptosis (14, 19). In the context of the viral genome,
LAT promotes neuronal survival in TG of infected rabbits (45)
and in acutely infected mice (1). Furthermore, LAT reduces
apoptosis in infected tissue culture cells (18).
Infection of cultured human cells with HSV-1 leads to pro-
duction and secretion of alpha interferon (IFN-) and IFN-
(reviewed in reference 22). HSV-1 glycoprotein D induces
IFN- production in mononuclear cells, resulting in activation
of IFN regulatory factor 3 (IRF-3). ICP0, ICP34.5, and Us11
are the known viral genes that block the effects of IFN activa-
tion and allow efficient viral replication. A recent study has
demonstrated that an ICP0 mutant virus still inhibits IFN-
production, suggesting that an unknown viral function inhibits
IFN- production (34). In addition to possessing potent anti-
viral activity, IFNs regulate cell growth, apoptosis, inflamma-
tion, and the stress response and have immunomodulatory
FIG. 1. Morphology of SK-N-SH cells infected with HSV-1. (A) TRL and IRL indicate the terminal and inverted long repeats in the HSV-1
genome. IRS and TRS indicate the inverted and terminal short repeats. UL and US indicate the unique long and unique short regions. The IRL
is expanded. The TRL contains the same genes except they are flipped left to right (indicated by the closed triangle). (B) Schematic of genes within
the long repeats. The large arrow indicates the primary LAT transcript. The solid rectangle represents the very stable 2-kb LAT intron. The LAT
TATA box is indicated by TATA. The start of LAT transcription is indicated by the arrow at1 (genomic nucleotide 118801). The relative position
of the AL transcript is also presented, and the positions of the AL transcript are given using the numbering system of LAT. Several restriction
enzyme sites and the relative locations of the ICP0 and ICP34.5 transcripts are shown for reference. The position of the deletion in dLAT2903
(161 to 1499) is denoted by the Xs. This deletion is present in both copies of the repeats (indicated by the black triangle in the TRL); thus,
dLAT2903 is a LAT null mutant because the core promoter and LAT coding sequences are deleted (46, 47). In addition, dLAT2903 does not
express AL gene products (42). (C) SK-N-SH cultures were infected with dLAT2903 or wt HSV-1 (multiplicity of infection [MOI]  8). One hour
after inoculation with the virus at 37°C, the inoculum was removed and the cells were washed three times (10 ml each wash) with phosphate-
buffered saline to remove residual virus. Fresh medium was then added to the cultures. At 24 h after infection, Hoechst 33412 staining was
performed. Apoptotic cells were counted, and the percentage of apoptotic cells is given. At least 200 cells from each culture were examined from
three different experiments. Means were compared by the Tukey-Kramer test at a 5% significance level. The differences between dLAT2903 and
LAT (wt or dLAT2903R) or mock infected versus virus infected were significant. At 48 h after infection, the amount of virus was determined
by freeze-thawing the infected cells and pelleting the debris. The amount of virus on rabbit skin cells was calculated. The results are the mean of
three independent studies.
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activity (22). There are two main types of IFN, formerly
termed type I and type II. Type I IFN includes IFN-, IFN-,
IFN-, and IFN-; type II IFN is IFN-	 (22). Most cell types
can produce IFN- and IFN-, whereas IFN-	 is predomi-
nantly produced in natural killer cells, CD4 T helper cells,
and CD8 cytotoxic T cells. Although there is only one IFN-
gene and one IFN-	 gene, there are numerous IFN- genes,
each encoding slightly different protein isoforms (22). Collec-
tively, the various forms of IFN are important regulators of the
innate and adaptive immune response.
In this study, we tested whether the LAT locus influences
IFN RNA expression in human neuroblastoma cells (SK-N-
SH), mouse neuroblastoma cells (neuro-2A), human lung cells
(HEL), and TG of acutely infected BALB/c mice. Infection of
SK-N-SH or neuro-2A cells, but not HEL cells, with wt virus
delayed IFN- and IFN- RNA expression compared to a
virus lacking LAT and AL (dLAT2903). When neuro-2A cells
were infected with dLAT2903, higher levels of IFN- promoter
activity were expressed relative to cells infected with a wt
strain. IFN- and IFN- expression in TG of acutely infected
mice was also detected earlier when mice were infected with
dLAT2903. Finally, there was a decrease in IFN-	 production
and secretion by wt HSV-1 infected TG cells, relative to
dLAT2903-infected TG cells. These results suggested that
LAT or AL gene products delay IFN expression in a neuronal
cell-type-specific manner.
MATERIALS AND METHODS
Cells and viruses. Cells were plated at a density of 5
 105 cells/100-mm plastic
dish in Earl’s modified Eagle’s medium supplemented with 5% fetal bovine
serum. All medium contained penicillin (10 U/ml) and streptomycin (100 g/ml).
SK-N-SH (human neuroblastoma cells), neuro-2A (mouse neuroblastoma cells),
and human embryonic lung cells (HEL cells) were obtained from the American
Type Culture Collection (Rockville, MD) and split in a 1:4 ratio every 3 to 5 days.
All parental and mutant viruses were plaque purified three times and passed
only one or two times prior to use. wt McKrae, dLAT2903, and dLAT2903R
were described previously (48, 49). Rabbit skin cells were used for preparation of
virus stocks. Virus from infected cell lysate was prepared by freeze-thawing three
times (70 to 37°C). Cell debris was removed by centrifugation (10,000
 g, 1 h),
and the supernatant containing virus was aliqouted and stored at 70°C. Mock-
infected cells were prepared in the same fashion. The human IFN- promoter
was not stimulated when undiluted medium from mock-infected cells was added
to neuro-2A cells. If virus was pelleted from stock preparations, the supernatant
did not activate the IFN- promoter when added to neuro-2A cells (data not
shown).
RNA preparation, reverse transcription-PCR (RT-PCR), and cDNA cloning.
TG samples were collected and snap frozen on dry ice. One milliliter of TRIZOL
reagent was added (Invitrogen, Carlsbad, CA), and RNA was prepared accord-
ing to the manufacturer’s instructions. For each time point, RNA was prepared
from three mice (six total TG). Total RNA was prepared from cultured cells
essentially as described by the manufacturer using TRIZOL. RNA samples were
subjected to DNaseI digestion to remove trace amounts of contaminating DNA.
RNA concentrations were determined initially by measuring the optical density
at 260 nm, and the integrity of the total RNA was monitored by running a 1.2%
formaldehyde agarose gel with 0.5 to 1 g of RNA.
First-strand cDNA synthesis was performed with the SuperScript First-Strand
Synthesis System for RT-PCR (Invitrogen) using equal amounts of total RNA (1
to 2 g) and oligo(dT)12-16 (for cellular genes) or random hexamers (for HSV-1
genes).
PCR was carried out in a 20-l reaction mixture that contained 0.5 M of the
designated gene specific primers (Table 2), 1/10 of the cDNA reaction mixture,
2.5 to 5 mM MgCl2, 25 to 100 M deoxynucleoside triphosphate, and 1 U of Taq
DNA polymerase. LAT cDNA was amplified using the GC-rich PCR system
(Roche).
IFN- cDNA was amplified using AccuPrime. The Taq DNA polymerase
system (Invitrogen) was used for DNA sequencing. PCRs were started with a
3-min incubation at 94°C; 20 to 36 cycles of 30 s at 95°C, 45 s at the annealing
temperature, and 72°C for 20 to 45 s; and then 72°C for 7 min. After amplifica-
tion, 10 l of each reaction mixture was analyzed by 1.5% agarose gel electro-
phoresis. The IFN- band was excised and cloned into the TA Vector system
(TOPO TA cloning kit; Invitrogen). Plasmid DNA was purified using a Plasmid
Mini Kit (QIAGEN) and then sequenced. Sequence data were analyzed using
GenBank (National Center for Biotechnology Information).
Plasmid constructs. The human IFN- promoter (110 to  20) linked to the
bacterial chloramphenicol acetyltransferase (CAT) gene was obtained from
Stavros Lomvardas (Columbia University, New York). This minimal promoter
contains the essential promoter elements that are activated by virus infection or
other IFN signaling pathways (36). The pISRE plasmid is a CAT reporter
construct that contains four consensus interferon-stimulated response elements
(ISRE) from the ISG15 promoter that is upstream of a minimal HIV promoter
construct. The pISRE plasmid was obtained from L. Zhang (University of Ne-
braska). CAT activity was examined as described previously (16, 17, 74).
Mouse studies. Adult female BALB/c mice (54 to 82 days old) were obtained
from Charles River Laboratory and were used for these studies. Mice were
ocularly infected with an infectious dose of 2 
 105 PFU/eye. Mice were bilat-
erally infected without scarification by placing the virus (2 l of inoculum) into
the conjunctival cul-de-sac, closing the eye, and rubbing the lid gently against the
eye for 30 s. Prior to infection, mice were lightly anesthetized with isoflurane
(Alocarbon Laboratories, River Edge, N.J.). The mice were observed daily dur-
ing the studies and were euthanized by CO2 inhalation at the indicated time
points.
For IFN protein detection, sex- and age-matched BALB/c mice were either
mock infected (mock) or infected with dLAT2903, wt HSV-1, or dLAT2903R.
Five days postinfection, all animals were sacrificed, and TG were aseptically
collected and treated with collagenase IV (Sigma). Single-cell suspensions were
prepared and washed three times in sterile Dulbecco’s modified Eagle’s com-
FIG. 2. Gene expression following infection of SK-N-SH cells with
HSV-1. SK-N-SH cultures were infected with an LAT mutant
(dLAT2903) or a LAT-expressing strain of HSV-1 (wt McKrae or
dLAT2903R) at an MOI of 8. Shown in this study are cells infected
with wt HSV-1. The results for dLAT2903R and wt McKrae were the
same. Total RNA was prepared at the indicated time (hours) after
infection using procedures described in Materials and Methods. Two
micrograms of total RNA was used for cDNA synthesis using random
primers. PCR was then performed using 1/10 of the cDNA reaction
mixture and the primers described in Table 2. (A) Analysis of IFN
expression in SK-N-SH cells after infection. All IFN- subtypes were
amplified with primers corresponding to the conserved regions of the
respective human IFN- subtypes. The IFN-amplified products were
excised and sequenced to confirm they were in fact IFN-amplified
bands. The panel marked Total RNA contains 1 g of total RNA
electrophoresed on a 1% formaldehyde gel. The number of PCR cycles
used to amplify cDNA for IFN- was 36 and the number of cycles used
to amplify IFN- or IFN-	 was 34. (B) Analysis of viral gene expres-
sion after infection. A total of 31 PCR cycles were used to amplify the
respective viral genes. The primers used for PCR amplification are
described in Table 1. These results are representative of three inde-
pendent experiments. vhs, virion host shutoff.
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plete medium. The TG cell suspensions were placed in triplicate wells at 106 total
cells per well and either left untreated (mock or negative control) or stimulated
in vitro at 37°C for 96 h using heat-inactivated HSV-1 as the antigen. As a
positive control, TG cell suspensions were stimulated with concanavalin A (data
not shown) (Sigma). For each condition, the IFN protein produced and secreted
in the supernatant of cultured cells was quantified by an enzyme-linked immu-
nosorbent assay (ELISA) sandwich kit (Pharmingen, San Diego, CA).
RESULTS
LAT influences cytotoxicity and apoptosis in SK-N-SH cells.
SK-N-SH cells are human neuroblastoma cells that have been
used to examine apoptosis after HSV-1 infection (10, 11). In
this study, we compared the level of apoptosis induced in
SK-N-SH cells by wt HSV-1 (McKrae strain), a LAT deletion
mutant (dLAT2903), or the marker-rescued dLAT2903
(dLAT2903R) (Fig. 1A and B). dLAT2903 contains a deletion
from 161 to 1667 relative to the start of the primary 8.3-kb
LAT and thus does not express detectable levels of LAT (48,
49) or the AL transcript (44). SK-N-SH cells productively
infected with dLAT2903 has consistently led to 30% apopto-
tic cells at 24 h after infection, as judged by Hoechst 33342
staining (Fig. 1C). In contrast, SK-N-SH cells infected with wt
McKrae or dLAT2903R (the rescued LAT mutant that be-
haves as wt McKrae) had approximately 14% apoptotic cells at
24 h postinfection. The differences in apoptosis between the
LAT (wt McKrae or dLAT2903R)-infected cells were signif-
icantly different (P  0.05) from levels of apoptosis in cells
infected with dLAT2903 when these differences were analyzed
using a Tukey-Kramer test at a 5% significance level. Many of
the cells infected with dLAT2903 contained nuclei that ap-
peared to have “collapsed” by 24 h postinfection. Although
LAT played a role in inhibiting apoptosis in productively in-
fected SK-N-SH cells, the end point virus titers were similar
regardless of whether cells were infected with wt McKrae,
dLAT2903R, or dLAT2903. The fact that HSV-1 contains sev-
eral antiapoptosis genes (3) and that differences between
dLAT2903 versus wt HSV-1 were not detected until 24 h after
infection may explain the similarity in virus titers.
LAT delays IFN- and IFN- RNA expression in SK-N-SH
cells. When SK-N-SH cells were infected with dLAT2903,
IFN- RNA was detected at 4, 8, and 16 h after infection (Fig.
2A; right). In contrast, IFN- RNA expression was not readily
detected until 16 h after infection when SK-N-SH cells were
infected with wt McKrae (Fig. 2A) or dLAT2903R (data not
shown). In addition, SK-N-SH cells infected with dLAT2903
contained readily detectable levels of IFN- RNA by 8 h after
infection. Although a small amount of IFN- RNA expression
was detected at 8 h after infection with LAT viruses (i.e.,
either wt McKrae or dLAT2903R) (Fig. 2A; left), it was not
easily detected until 16 h after infection. IFN-	 was not de-
tected until 16 h after infection, regardless of whether SK-
N-SH cultures were infected with dLAT2903 or wt HSV-1. The
intensity of the IFN-	-amplified cDNA was consistently higher
in dLAT2903-infected SK-N-SH cells. As expected, IFN-,
IFN-, and IFN-	 RNA was not detected in mock-infected
cells.
For these studies, we used readings at an optical density of
260 nm and total RNA as methods to ensure that the same
amounts of total RNA were used for RT-PCR (Fig. 2A). As
another control, we examined the levels of four viral transcripts
(virion host shutoff, ICP0, ICP27, and LAT) in productively
FIG. 3. Induction of different IFN- subtypes in SK-N-SH cells infected with McKrae or dLAT2903. (A) The IFN- cDNAs generated by
RT-PCR from SK-N-SH cells infected with McKrae or dLAT2903 (Fig. 2A) were cloned as described in Materials and Methods. Randomly
selected clones were sequenced and the sequence analyzed to identify which IFN- subtype was present. (B) Primers that specifically amplify
IFN-5 or IFN-6 were synthesized (Table 2) and used for RT-PCR as described in Materials and Methods.
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infected SK-N-SH cultures. Cultures infected with dLAT2903
or wt McKrae exhibited no dramatic qualitative or quantitative
difference in ICP0, ICP27, or virion host shutoff RNA expres-
sion (Fig. 2B). This result was consistent with the finding that
similar virus titers were produced in cells infected with
dLAT2903 or wt HSV-1 (Fig. 1). LAT was not expressed when
cultures were infected with dLAT2903 because the core LAT
promoter and the first 1.5 kb of LAT coding sequences were
deleted (48). As expected, LAT was detected as early as 4 h
after infection following infection with wt McKrae. In sum-
mary, these studies indicated that sequences within the LAT
locus played a role in delaying expression of IFN- RNA and
IFN- RNA in SK-N-SH cells.
Identification of IFN- subtypes in SK-N-SH cells after
infection. The IFN- gene family has extensive similarity at the
nucleotide level and contains numerous family members that
encode slightly different protein subtypes (22). IFN- subtypes
are expressed in a cell-type-dependent fashion, suggesting they
have different effects on certain cells (13). In contrast, there is
a single IFN- gene and a single IFN-	 gene. The primers that
were used to amplify human IFN-RNA will amplify all IFN-
subtypes (33). Thus, it was possible to compare the distribution
of IFN- subtypes in SK-N-SH cells after infection with
dLAT2903 or wt McKrae by cloning and sequencing the PCR-
amplified IFN- cDNA band. When cultures of SK-N-SH cells
were infected with dLAT2903, approximately 53% of the
IFN- subtypes expressed were IFN-5, whereas 32% of the
clones were IFN-5 when cells were infected with wt McKrae
(Fig. 3A). Subtle differences were also detected among other
isotypes, for example, IFN-1, IFN-6, and IFN-14.
To further test whether sequences within the LAT locus
delayed expression of IFN- subtypes, primers that specifically
amplify IFN-5 or IFN-6 were designed and tested. The
IFN-5-specific primers amplified a cDNA product at 4 h after
infection when SK-N-SH cells were infected with dLAT2903
but not until 8 h after infection with wt McKrae (Fig. 3B).
IFN-6-amplified cDNA products were readily detected as
early at 8 h after infection with dLAT2903 but not until 16 h
after infection with wt McKrae.
Pretreatment of SK-N-SH cells with IFN- had a dramatic
impact on the number of plaques formed in SK-N-SH cells
(Fig. 4), confirming that IFN has antiviral activity against
HSV-1 in these cells. The effects of IFN- on virus replication
were slightly higher when cultures were infected with
dLAT2903 rather than wt McKrae. Although the LAT locus
delayed IFN RNA expression in productively infected SK-
N-SH cultures, pretreatment of SK-N-SH cells with IFN did
not show a dramatic difference between the growth properties
of dLAT2903 and LAT strains.
Analysis of IFN expression in neuro-2A and HEL cells. To
test whether the LAT locus influenced IFN expression in other
cell types, we infected mouse neuroblastoma cells (neuro-2A)
or human lung cells (HEL) with dLAT2903 or wt McKrae and
examined IFN RNA at different times after infection. In keep-
ing with the results obtained with SK-N-SH cells, qualitative
differences in IFN- and IFN-4 RNA expression were ob-
served in neuro-2A cells (Fig. 5A). In contrast to the results
obtained with SK-N-SH or neuro-2A cells, no obvious differ-
ences in IFN- RNA expression were detected in HEL cells
infected with dLAT2903 versus wt McKrae (Fig. 5B). Further-
FIG. 4. Pretreatment of SK-N-SH cells with IFN inhibits HSV-1
plaque formation. SK-N-SH cells were seeded in six-well plates, and
the cells reached 80 to 90% confluence. On the next day, SK-N-SH
cultures were treated with IFN- (0.1 to 1,000 U) (Calbiochem
407297) for 6 h and then infected with HSV-1 (MOI 0.01). One hour
later, the medium was replaced with Earl’s modified Eagle’s medium
containing 10% fetal calf serum and the same concentration of IFN
used as in the 6-h pretreatment. The number of plaques was counted
48 to 72 h after infection. The number of plaques without IFN- was
set at 100%. Although IFN- treatment had a slight effect on the size
of plaques, we did not observe dramatic differences between
dLAT2903 and LAT strains (data not shown). These results are the
average of five different experiments.
FIG. 5. Induction of IFN- in HEL or neuro-2A cells infected with
McKrae or dLAT2903. Neuro-2A cells (A) or HEL cells (B) were
infected with dLAT2903 or a LAT-expressing strain of HSV-1 (wt
McKrae or dLAT2903R) at an MOI of 8. Total RNA was prepared at
the indicated time (hours) after infection. Two micrograms of total
RNA was used for cDNA synthesis using random primers. PCR was
then performed using 1/10 of the cDNA reaction mixture and the
primers described in Table 2.
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more, no dramatic differences were observed using primers
that amplified IFN-5 or IFN-6 (Fig. 5B) or primers that
amplified all IFN- cDNAs (data not shown). As with SK-
N-SH cells, IFN-	 was not detected in HEL cells until 16 h
after infection with either dLAT2903 or wt HSV-1. Viral gene
expression and virus titers were nearly identical in HEL and
neuro-2A cells infected with dLAT2903 or wt McKrae (data
not shown). These findings suggested that cell-type-specific
factors played a role with respect to whether the LAT locus
delayed IFN RNA expression.
Additional studies were performed to test whether infection
of cultured cells with dLAT2903 contained higher levels of
IFN- promoter activity than cells infected with dLAT2903R.
For these studies, two promoter constructs were used: the
human IFN- promoter and a minimal HIV promoter that
contains four copies of a consensus ISRE. Neuro-2A cells were
used for these studies because they can be readily transfected,
whereas HEL and SK-N-SH cells do not transfect efficiently. In
four separate experiments, IFN- promoter activity was higher
in neuro-2A cells infected with dLAT2903 versus dLAT2903R
(Table 1). In contrast, pISRE promoter activity was not differ-
ent regardless of whether the cells were infected with
dLAT2903 or dLAT2903R. The data was analyzed using a
Student’s t test (two tailed). The IFN- promoter activity in
cells infected with dLAT2903 versus dLAT2903R was signifi-
cantly different (P  0.0046), but it was not when comparing
pISRE promoter activity (P  0.94). Although these studies
support the findings that a factor encoded by the LAT locus
inhibits the IFN response, they also suggest that not all IFN
signaling pathways are inhibited by the LAT locus.
The LAT locus delayed IFN expression in TG of infected
mice. Although the data obtained from neuroblastoma cells
suggested that the LAT locus delayed IFN RNA expression
during productive infection (Fig. 2 to 5A), it was also clear that
the LAT locus had no dramatic effect on IFN RNA expression
in HEL cells (Fig. 5B). Since LAT has an effect on the latency
reactivation cycle but does not have a dramatic effect on pro-
ductive infection (20, 21), we hypothesized that if the LAT
locus played a role in delaying IFN RNA expression, this might
only occur in neuronal cell types. To further test whether LAT
or other genes within the LAT locus influenced IFN RNA
expression in TG of acutely infected mice, adult female
BALB/c mice were infected with LAT strains or dLAT2903,
and expression of IFN RNA in TG was analyzed by RT-PCR.
We initially examined IFN- expression in TG of infected mice
(Fig. 6). Mouse-specific primers were used for this study be-
cause there are differences in mouse and human sequences
(Table 2). IFN- RNA expression was readily detected at 4
days after infection when mice were infected with dLAT2903
(Fig. 6A). In contrast, IFN-RNA expression was not detected
until 6 days after infection with wt McKrae (Fig. 6A) or
dLAT2903R (data not shown). As expected, LAT was not
detected in mice infected with dLAT2903 but was readily de-
tected in mice infected with wt HSV-1. In keeping with previ-
ous studies (46), dLAT2903 and wt McKrae grew to similar
titers in the eyes and TG of infected mice (data not shown).
The mouse-specific IFN- primers were designed to amplify
all IFN- subtypes, allowing us to compare the distribution of
subtypes expressed in TG after infection. The IFN- RT-PCR
band was eluted from the agarose gel and cloned, and the
plasmid inserts were sequenced. At 4 days after infection, no
clones were obtained when the region of the gel encompassing
the amplified IFN- band was excised from samples prepared
from mice infected with wt McKrae (Fig. 6B). Twelve of 13
clones (92%) that were obtained from the RT-PCR products
in mice infected with dLAT2903 at 4 days after infection and
18 of 24 (75%) at day 6 after infection were IFN-4. Similarly,
78 and 67% of the clones from mice infected with wt McKrae
were also IFN-4 on days 6 and 8 after infection, respectively.
Interestingly, mice infected with wt McKrae contained 8.6 or
33% IFN-B subtypes at 6 or 8 days after infection, respec-
tively, whereas IFN-B was not detected in mice infected with
dLAT2903 (Fig. 6B).
Mice infected with dLAT2903 expressed IFN- in TG as
early as 4 days after infection, whereas mice infected with wt
McKrae or dLAT2903R did not express IFN- until 6 days
FIG. 6. Induction of IFN- in TG of mice infected with McKrae or
dLAT2903. (A) BALB/c mice were infected with HSV-1 as described
in Materials and Methods. At the indicated times after infection, TG
were harvested and total RNA prepared (TG from 2 mice/time point).
RT-PCR using the designated primers was performed (Table 2). All
mouse IFN- subtypes were amplified using consensus primers that
are located within the conserved region of the IFN- RNA. The top
panel shows the corresponding levels of -actin mRNA as a loading
control. (B) The IFN- cDNA band that contains a mixture of the
IFN- subtypes was excised and cloned, and the insert was sequenced.
The band at 4 days after infection (McKrae) did not yield clones, which
was expected because we were unable to amplify IFN- cDNAs at this
time.
TABLE 1. Activation of the human IFN- promoter and ISRE-
dependent transcription, following infection with HSV-1a
Promoter
dLAT2903 dLAT2903R
1 2 3 4 1 2 3 4
IFN- 3.4 5.5 4.1 4.3 1.5 2.9 1.7 1.5
pISRE 6.5 3.9 5.7 6.8 3.4 5.6
a Cultures of neuro-2A cells were transfected with the designated promoter
constructs (1 g) plasmid DNA. At 24 h after transfection, the cultures were
infected with the designated viruses using an MOI of 4. At 40 h after transfection,
the total cell lysate was collected and CAT activity was measured. The levels of
acetylated chloramphenicol was measured using a BioRad Molecular Imager
FX. The levels of promoter activity in mock-infected cells were set and the fold
of stimulation was then calculated for each promoter. The results of hree inde-
pendent experiments are shown for the two promoters. Four experiments (1 to
4) are shown for each construct.
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after infection (Fig. 7). We also synthesized IFN--specific
primers that amplified only IFN-4 (67), IFN-14, or IFN-B.
As predicted from the distribution of IFN- subtypes (Fig. 6B),
IFN-4–IFN-14 products were detected earlier in TG of mice
infected with dLAT2903 (4 days after infection) versus mice
infected with wt McKrae or dLAT2903R (6 days after infec-
tion). Furthermore, IFN-B was detected in TG of mice in-
fected with wt McKrae or dLAT2903R but not dLAT2903
(Fig. 7), which was consistent with the sequencing analysis of
IFN- subtypes expressed after infection (Fig. 6B). IFN-	
RNA expression was readily detected in TG of mice infected
with dLAT2903 at 2 days after infection, whereas it has been
difficult to detect IFN-	 RNA in TG of mice infected with
dLAT2903R or wt HSV-1 until 4 days after infection. ICP27,
-actin, and p53 RNA expression was similar in TG of infected
mice, regardless of whether mice were infected with
dLAT2903, dLAT2903R, or wt HSV-1. This result is consistent
with the finding that similar levels of virus were detected in TG
of mice regardless of whether the mice were infected with
LAT virus strains or strains lacking LAT. In summary, this
study indicated that the LAT locus encodes a factor that di-
rectly or indirectly delayed RNA expression of certain subtypes
of IFN- and IFN- in TG of infected mice. Furthermore, wt
HSV-1, but not dLAT2903, appeared to induce expression of
IFN-B RNA in TG of acutely infected mice.
Decreased IFN- production by wt HSV-1- and dLAT2903R-
infected TG cells compared to dLAT2903-infected TG cells.
Next, we sought to determine whether the presence of the LAT
locus would interfere with the expression of interferon at the
protein level. Groups of BALB/c mice were either mock in-
fected or infected with dLAT2903, wt HSV-1, or dLAT2903R.
Five days postinfection, TG were removed from each group,
single-cell suspensions were made, and 106 TG cells/well were
either left untreated (mock) or stimulated in vitro with wt
HSV-1. The amount of IFN-	 protein produced in the super-
natant of stimulated TG cells was then detected by a sandwich
ELISA and normalized to the total number of TG cells (i.e.,
106). As shown in Fig. 8, with or without in vitro restimulation,
TG cells from the dLAT2903 group produced significantly
FIG. 7. Expression of IFN in TG of mice infected with dLAT2903
or LAT strains of HSV-1. BALB/c mice were infected with HSV-1 as
described in Materials and Methods. At the indicated times after
infection, TG were harvested, and total RNA was prepared. RT-PCR
using the designated primers (Table 1) was performed. As loading
controls, the expression levels of -actin and p53 are shown in the
bottom panels. The results are representative of two different experi-
ments.
TABLE 2. Nucleotide sequences of PCR primers
Gene Primer sequences Product (bp) Accession no.
HSV-1
VHS TGCTACATTCCCACGATCAA, AGGTCCTCGTCGTCTTCGTA 346 AF007815
ICP0 ACAGACCCCCAACACCTACA, GCGTATGAGTCAGTGGGGA 150 AF431736
ICP27 CCCTTTCTCCAGTGCTACCTGAA, GTGCGTGTCTAGGATTTCGATC 256
LAT TTGGCGGTAACCCCGATTGTTTATCTCAGG & TCGTTCCGTCGCCGGGATGTTTCGTTCGT 200
Human
IFN- AGAATCTCTCCTTTCTCCTG, TCTGACAACCTCCCAGGCACA 369
IFN-6 CTGGACTGTGATCTGCCTCA, CTTCAGCCTTCTGGAACTGG 169 gi:11128014
IFN-5 CCAGTTCCAGAAGG CTCAAG, TGTCTTCCACTCCAACCTCC 197 gi:4504596
IFN- TGGGAGGATTCTGCATTACC, CAGCATCTGCTGGTTGAAGA 200 gi:4504602
IFN-	 TGACCAGAGCATCCAAAAGA, ATATTGCAGGCAGGACAACC 280 gi:10835170
Mouse
IFN- TCTCCTGCCTGAAGGACAGG, GAGCAGAAGTCTGGA 320
IFN-B TGGCAGTGATGAGCTACTGG, ATCTGCTGGGTCAGCTCAGT 240 gi:6680370
IFN-14 TGCTGGTGATGAGCTACTGG, GAGCCTTCTTGATCTGCTGG 200 gi:29468971
IFN-4 CTGGTCAGCCTGTTCTCTAGGATGT, TCAGAGGAGGTTCCTGCATCAC 314
IFN- CCCTATGGAGATGA CGGAGA, TCCCACGTCAATCTTTCCTC 222 gi:6754303
IFN-	 GAAAAGGAG TCGCTGCTGAT, AGATACAACCCCGCAATCAC 319 gi:2850152
p53 GTACCTTATGAGCCACCCGA, CTGTAGCATGGGCATCCTTT 446 gi:6755880
-Actin GTGGGGCGCCCCAGGCACCA, CTCCTTAATGTCACGCACGATTTC 550
a The primers directed against glycoprotein C (gC), -actin, and LAT were described previously (41). The human IFN- primer that amplifies all human subtypes
of IFN- was described previously (34). The mouse IFN- primer that amplifies all human subtypes of IFN- was designed based on the consensus sequence of the
respective IFN- subtypes in mice. The mouse IFN-4 primers were described previously (65). All primers are presented in a 5-to-3 direction. The first primer is the
forward primer and the second is the reverse primer.
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more IFN-	 than TG cells from the LAT groups
(dLAT2903R or wt) (P 0.001). All three infected groups also
produced significantly more IFN-	 than the mock-infected
group (P  0.001) Preliminary IFN-	 enzyme-linked immuno-
spot assays suggested a higher frequency of IFN-	-secreting
cells in TG cells lacking LAT than in LAT TG cells (unpub-
lished data). Taken together, these results suggest that the
LAT locus directly or indirectly impairs IFN expression at both
the RNA and the protein level.
DISCUSSION
In this study, we provide evidence that a factor encoded by
the LAT locus delayed RNA and protein expression of certain
IFNs in neuroblastoma cells (SK-N-SH or neuro-2A) and TG
of infected mice but not in HEL cells. Consistent with these
studies, we also demonstrated that the LAT locus reduced
IFN- promoter activity in infected neuro-2A cells. The LAT
deletion mutant that was used for this study has at least three
genetic elements deleted: (i) the stable 2-kb LAT that has been
reported to encode a protein capable of replacing ICP0 func-
tions during reactivation from latency (62, 63); (ii) the first 1.5
kb of LAT that contains only a portion of the stable 2-kb stable
LAT, but a fragment that is sufficient for high levels of spon-
taneous reactivation in the rabbit eye model (49) or TG ex-
plant-induced reactivation in the mouse (46); and (iii) a tran-
script located within the 5 end of LAT and the LAT promoter
that is antisense to LAT (the AL transcript) (44). In addition
to the first 1.5-kb LAT promoting spontaneous reactivation
(48, 49), this same fragment inhibits caspase 8-induced apo-
ptosis very efficiently (43). A LAT fragment that contains the
first 2.8 kb of LAT coding sequences (includes the stable 2-kb
LAT) efficiently inhibits caspase 9-induced apoptosis (19) but
does not inhibit caspase 8-induced apoptosis any better than
the 1.5-kb LAT fragment (48, 49). The function of the AL gene
is currently unknown. Studies are in progress to test whether
LAT or the AL gene delays IFN RNA expression.
In the context of productive infection in SK-N-SH cells, the
ability of the LAT locus to stimulate virus production was
marginal when cultures were pretreated with IFN- (Fig. 4).
Since HSV-1 encodes several other genes that inhibit the del-
eterious effects of IFN (22, 34), these genes apparently com-
pensate for the loss of this factor or this factor is only impor-
tant during a specific stage of the latency reactivation cycle.
Interestingly, a recent report demonstrated that an ICP0 mu-
tant virus retains the ability to inhibit IFN- production (34),
which supports our finding that the LAT locus inhibits IFN-
expression in SK-N-SH cells. If LAT is responsible for delaying
IFN RNA expression, we suggest that LAT RNA, not a LAT
protein, inhibits IFN RNA expression. There is precedence for
non-protein-encoding RNAs that inhibit the IFN response.
For example, a small Epstein-Barr virus RNA is expressed in
latently infected B cells and has been reported to inhibit the
IFN response (39). An adenovirus nonpolyadenylated RNA
can also repress the IFN response (57). Finally, a cellular RNA
that does not appear to encode a protein inhibits IFN-induced
apoptosis in HeLa cells (58).
In contrast to the results obtained in SK-N-SH cells,
neuro-2A cells, or TG of acutely infected mice, LAT did not
delay IFN RNA expression in human lung fibroblasts (HEL)
(Fig. 5B). Mutation of the splice acceptor site or the splice
donor site that generates the 2-kb LAT drastically reduces
expression of the 2-kb LAT during productive infection but has
little effect on expression during latency (2). This study sug-
gests that processing of LAT is cell type specific and may
regulate LAT function. It is also possible that AL gene prod-
ucts are expressed at higher levels in neuronal cell types or that
the putative AL protein has novel functions in neuronal cell
types.
The finding that the LAT locus delayed expression of
IFN-4 RNA and reduced the frequency of IFN-4 RNA in
TG of infected mice is significant because IFN-4 expression is
an “immediate early” response to virus infection (31). After
virus infection, phosphorylation of interferon regulatory factor
3 (IRF3) activates IFN-4 gene expression. IFN-4 and IFN-
subsequently activate expression of other interferon regulatory
factors (IFN-stimulated gene factor 3 and IRF7, for example)
that stimulate expression of the remaining IFN- subtypes.
More than a dozen mouse IFN- genes are clustered on chro-
mosome 4 (37, 53). The presence of multiple IFN- genes is
believed to be important because immediate early expression
of IFN-4 provides a rapid response to virus infection, while
sequential induction of delayed IFN- genes amplifies the pro-
tective response to virus infection. In general, it is believed that
IFN- subtype expression in mice is mediated by differences in
the respective promoters of the genes. Our findings suggest
that the LAT locus regulates expression of specific IFN-induc-
ible genes for the following reasons. (i) The LAT locus re-
pressed IFN-, but not pISRE, promoter activity in neuro-2A
cells. (ii) The LAT locus stimulated IFN-B RNA expression
but inhibited IFN-4 RNA expression in TG of infected mice.
In addition to blocking protein synthesis and establishing an
“antiviral” state, several interferon-stimulated genes have pro-
apoptosis activity(reviewed in reference 5). For example, IFN
induces RNA expression of TRAIL, Fas, Xaf-1, caspase 4,
caspase 8, RIDs, PKR, IRF-1, PML, RNase L, gelectin-9,
OAS-1 9-2 isozyme, and death-associated protein kinases. Of
FIG. 8. Decreased IFN secretion in TG from mice infected with wt
HSV-1 or dLAT2903R viruses. TG single-cell suspensions were ob-
tained from age- and sex-matched mice infected with dLAT2903, wt
HSV-1, or dLAT2903R at 5 days postinfection. Noninfected mice were
used as a negative control. For each reaction, an equivalent number of
cells from two TG were either left untreated (white bars) or incubated
in vitro at 37°C with heat-inactivated wt HSV-1 as a source of antigen
(black bars). The secreted IFN was measured 96 h later by a standard
sandwich ELISA assay. The results are representative of two different
experiments.
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particular note, the caspase 8 promoter is strongly regulated by
an interferon-sensitive response element in neuroblastoma
cells (4). Regardless of cell type or tissue histology, induction
of apoptosis by all IFN subtypes (IFN-, IFN-, or IFN-	)
involves caspase 8 signaling, activation of the caspase cascade,
release of cytochrome c, and DNA fragmentation (5). Produc-
tion of IFN during infection also regulates cytotoxic T lympho-
cyte responses (32, 55, 66). A long-term inflammatory response
occurs in TG of mice infected with HSV-1 (23, 26–28) or cattle
infected with bovine herpesvirus type 1 (73), and interferon
and other cytokines are produced. In TG of rabbits infected
with dLAT2903, there is an increase in the number of infiltrat-
ing cells (45). Furthermore, in mice there was a relative in-
crease in the level of IFN secretion by dLAT2903-infected TG
cells (Fig. 8). This suggests that the ability of the LAT locus to
decrease IFN RNA and protein levels resulted in reduced
lymphocyte infiltration in TG. In addition to the known effect
of IFN in promoting a type 1 T-helper-cell (Th1) response, a
critical arm in HSV immunity, the interference of LAT with
IFN expression may also decrease the probability of immune
mediated killing of infected neurons.
We hypothesize that the ability of the LAT locus to delay the
IFN response is important because it promotes neuronal sur-
vival by inhibiting apoptosis, preventing immune recognition
and allowing normal neuronal functions to continue after in-
fection. During the establishment and maintenance of latency,
the other virus-encoded IFN regulators would not be ex-
pressed. Since LAT and AL are regulated by sequences within
the LAT promoter, these functions are expressed at higher
levels during latency, in particular, LAT. The above-mentioned
effects are not mutually exclusive, and both may counteract the
host immune response and support efficient viral replication
and reactivation. Thus, inhibiting IFN expression may enhance
the long-term survival of infected neurons during the latency
reactivation cycle.
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